Publication | Open Access
Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer
22
Citations
35
References
2023
Year
ICI is also effective in elderly NSCLC patients, and treatment discontinuation due to irAEs may be a good prognostic marker.
| Year | Citations | |
|---|---|---|
Page 1
Page 1